Document is current
Any future updates will be listed below
-
Authors
Suzuki, Shiho
Suzuki, Keisuke https://orcid.org/0000-0003-0320-8993
Haruyama, Yasuo
Fujita, Hiroaki
Shiina, Tomohiko
Kobayashi, Saro
Shioda, Mukuto
Hida, Ryotaro
Hirata, Koichi
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 15 May 2025
First Online: 3 June 2025
Declarations
:
: The study was conducted in compliance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Dokkyo Medical University Hospital. The Institutional Review Board of Dokkyo Medical University Hospital waived the requirement for patients to sign informed consent forms on the basis of the retrospective, observational nature of the study.
: Not applicable.
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. S Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during the study. K Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo and Otsuka Pharmaceutical Co., Ltd., during the study. Y Haruyama, H Fujita, T Shiina, S Kobayashi, M Shioda and R Hida have nothing to disclose. K Hirata received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during the study.
